Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 556

1.

A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood.

Poodt J, Fijnheer R, Walsh IB, Hermans MH.

Hematol Oncol. 2006 Dec;24(4):227-33.

PMID:
17006961
[PubMed - indexed for MEDLINE]
2.

Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).

Michiels JJ, Bernema Z, Van Bockstaele D, De Raeve H, Schroyens W.

Pathol Biol (Paris). 2007 Mar;55(2):92-104. Epub 2006 Aug 21. Review.

PMID:
16919893
[PubMed - indexed for MEDLINE]
3.

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.

Larsen TS, Pallisgaard N, Møller MB, Hasselbalch HC.

Eur J Haematol. 2007 Dec;79(6):508-15. Epub 2007 Oct 23.

PMID:
17961178
[PubMed - indexed for MEDLINE]
4.

A tetra-primer polymerase chain reaction approach for the detection of JAK2 V617F mutation.

Koksal V, Etlik O, Arican-Baris ST, Baris I.

Genet Test. 2007 Winter;11(4):463-6. doi: 10.1089/gte.2007.0051.

PMID:
18294066
[PubMed - indexed for MEDLINE]
5.

The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.

Zhan H, Spivak JL.

Clin Adv Hematol Oncol. 2009 May;7(5):334-42. Review.

PMID:
19521323
[PubMed - indexed for MEDLINE]
6.

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].

Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.

Orv Hetil. 2006 Nov 12;147(45):2175-9. Hungarian.

PMID:
17402211
[PubMed - indexed for MEDLINE]
7.

The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders.

Larsen TS, Christensen JH, Hasselbalch HC, Pallisgaard N.

Br J Haematol. 2007 Mar;136(5):745-51.

PMID:
17313377
[PubMed - indexed for MEDLINE]
8.

Fast and reliable mutation detection of the complete exon 11-15 JAK2 coding region using non-isotopic RNase cleavage assay (NIRCA).

Kambas K, Mitroulis I, Kourtzelis I, Chrysanthopoulou A, Speletas M, Ritis K.

Eur J Haematol. 2009 Sep;83(3):215-9. doi: 10.1111/j.1600-0609.2009.01279.x. Epub 2009 Jun 2.

PMID:
19500139
[PubMed - indexed for MEDLINE]
9.

The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methods.

Lucia E, Martino B, Mammi C, Vigna E, Mazzone C, Gentile M, Qualtieri G, Bisconte MG, Naccarato M, Gentile C, Laganà C, Romeo F, Neri A, Nobile F, Morabito F.

Leuk Lymphoma. 2008 Oct;49(10):1907-15. doi: 10.1080/10428190802290652.

PMID:
18720212
[PubMed - indexed for MEDLINE]
10.

Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.

Teofili L, Giona F, Martini M, Cenci T, Guidi F, Torti L, Palumbo G, Amendola A, Foà R, Larocca LM.

J Clin Oncol. 2007 Mar 20;25(9):1048-53.

PMID:
17369568
[PubMed - indexed for MEDLINE]
11.

Identification of JAK2V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera.

Ganly P, Hanrahan V, Baker B, Romeril K.

Am J Hematol. 2007 Jan;82(1):80-2.

PMID:
16924638
[PubMed - indexed for MEDLINE]
12.

JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets.

Toyama K, Karasawa M, Yamane A, Irisawa H, Yokohama A, Saitoh T, Handa H, Matsushima T, Sawamura M, Miyawaki S, Murakami H, Nojima Y, Tsukamoto N.

Br J Haematol. 2007 Oct;139(1):64-9.

PMID:
17854308
[PubMed - indexed for MEDLINE]
13.

The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.

Hsieh PP, Olsen RJ, O'Malley DP, Konoplev SN, Hussong JW, Dunphy CH, Perkins SL, Cheng L, Lin P, Chang CC.

Mod Pathol. 2007 Sep;20(9):929-35. Epub 2007 Jul 20.

PMID:
17643100
[PubMed - indexed for MEDLINE]
Free Article
14.

The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical study.

Rudzki Z, Sacha T, Stój A, Czekalska S, Wójcik M, Skotnicki AB, Grabowska B, Zduńczyk A, Okoń K, Stachura J.

Int J Hematol. 2007 Aug;86(2):130-6.

PMID:
17875526
[PubMed - indexed for MEDLINE]
15.

Comparison of JAK2V617F mutation assessment employing different molecular diagnostic techniques.

Veneri D, Capuzzo E, de Matteis G, Franchini M, Baritono E, Benati M, Solero GP, Ambrosetti A, Quaresmini G, Pizzolo G.

Blood Transfus. 2009 Jul;7(3):204-9. doi: 10.2450/2009.0070-08.

PMID:
19657484
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms.

Oh ST, Gotlib J.

Expert Rev Hematol. 2010 Jun;3(3):323-37. doi: 10.1586/ehm.10.28. Review.

PMID:
21082983
[PubMed - indexed for MEDLINE]
17.

Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow.

Larsen TS, Pallisgaard N, Møller MB, Hasselbalch HC.

Leukemia. 2008 Jan;22(1):194-5. Epub 2007 Jul 12. No abstract available.

PMID:
17625603
[PubMed - indexed for MEDLINE]
18.

JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera.

Zhang S, Qiu H, Fischer BS, Li W, Duan L, Sun X, Xu W, Li J.

Leuk Lymphoma. 2008 Apr;49(4):696-9. doi: 10.1080/10428190701885537.

PMID:
18398736
[PubMed - indexed for MEDLINE]
19.

Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.

Hussein K, Brakensiek K, Buesche G, Buhr T, Wiese B, Kreipe H, Bock O.

Ann Hematol. 2007 Apr;86(4):245-53. Epub 2007 Jan 30.

PMID:
17262192
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk